Abbott 4Q Revenues: $6.2 billion (+2.8%) 4Q Loss: $476.2 million (earnings were $974.6 million in 4Q2005) FY Revenues: $22.5 billion (flat) FY Earnings: $1.7 billion (-49%) Comments: Adjusting both periods for the amendment of the Boehringer Ingelheim distribution agreement, net sales increased by 14.5% for the quarter and 11.6% for the year. Humira sales were $370 million in the quarter, up 31% and $1.2 billion for the year, up 38%. Depakote sales were $384 million in the qu...